Add-Aspirin
Menu
  • Home
  • Patients & Public
    • About Add-Aspirin
    • Participant Information
    • Participant FAQs
    • How do I join the trial?
    • Already taking part?
      • Trial Treatment
      • Newsletters for Participants
    • How we use your data
    • A notice for Participants in the Add-Aspirin Breast Cohort
    • A notice for Participants being randomised in Add-Aspirin from 1st April 2023
  • Centres
    • Eligibility
    • FAQs
    • Urinary thromboxane B2 sub-study
    • UK Co-enrolment
    • India Co-enrolment
    • Republic of Ireland Co-enrolment
    • Final Recruitment Numbers
  • News & Resources
    • News
    • Presentations, Posters & Abstracts
    • Publications
  • Unblinding
    • Unblinding for Republic of Ireland
    • Unblinding for India
  • Trainee Scheme
  • Member Resources
    • India Resources
      • Current India Specific CRFs (Protocol v9.0)
      • India Specific CRFs (superseded Protocol v7.0) - in use from 7th July 2021
      • India Specific CRFs (superseded Protocol v5)
      • Protocol Deviation
      • eDC/Data Management Training Video - India
    • Republic of Ireland Resources
      • Superseded patient documents
      • Substantial Amendment: Participant Recruitment Video
      • Protocol v8.0 documents and re-consent clarification
  • Sitemap
  • Members Area
    • Login

News

Add-Aspirin cancer trial completes recruitment after a decade of work

Posted by News Author on 28 May 2025
Cancer

Aspirin: Scientist crack how painkiller might stop cancers from spreading - BBC News

Link to the BBC News article ...

Posted by News Author on 06 Mar 2025
Cancer

All posts

  • 2025
    • May
    • March
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

Categories

  • Cancer
  • Documents
  • General
  • Events

News and Resources

  • News
  • Presentations, Posters & Abstracts
  • Publications

The trial is being jointly funded by Cancer Research UK (grant number C471 /A15015), the National Institute for Health Research Health Technology Assessment Programme (project number 12/01/38) and the MRC Clinical Trials Unit at UCL. In India, the Sir Dorabji Tata Trust provides funding.

Quick links

  • Register Participant
  • Unblind a participant
  • Contact Us

Social pages

  • twitter
  • rss
  • © 2025 Add-Aspirin, MRC CTU at UCL
  • Sitemap
  • RSS
  • Cookies
  • Page last updated: 14-Oct-2021 13:15